Yen-Wen Chen

Dr. Yen-Wen Chen

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2021 in Internal Medicine Journal
Verified
Journal Article
Open access
PDF file
YCYen-Wen Chen
Yen-Wen Chen
HLHsien-Tzung Liao
Hsien-Tzung Liao
Click on the article title to read more.

17 September 2021 in Research Square
Verified
Preprint
Open access
PDF file
PCPei-Ku Chen
Pei-Ku Chen
TKTzu-Ting Kuo
Tzu-Ting Kuo
SLSzu-Ying Lin
Szu-Ying Lin
JKJiang-Hwa Kao
Jiang-Hwa Kao
YCYen-Wen Chen
Yen-Wen Chen
Background Stroke is an uncommon but significant complication of cardiac surgery. Cutibacterium (previously known as Propionibacterium) rarely causes infective endocarditis (IE), accounting for approximately 0.3% of all IE cases. Hyperbaric oxygen therapy (HBOT), involving the administration of 100% oxygen at a pressure of > 1.4 atmospheres absolute, increases the partial pressure of oxygen; therefore, it is recommended as an adjunctive treatment for stroke and some infections. However, there are no data supporting HBOT as an adjunctive therapeutic option for ischemic stroke related to post-cardiac surgery due to IE caused by Cutibacterium acnes. Case presentation: This study reports the case of an 68-year-old male patient who underwent cardiac surgery for native-valve IE caused by C. acnes. He underwent HBOT on postoperative day 11 for the treatment of ischemic stroke. The patient received 20 sessions of HBOT along with 6-week antimicrobial treatment with ceftriaxone and rehabilitation programs. Conclusions We have summarized the patient’s successful recovery and our clinical experience regarding the use of HBOT in our clinical setting. HBOT is an effective adjunctive therapeutic option for ischemic stroke related to post-cardiac surgery due to IE caused by C. acnes.

14 December 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
YCYen-Wen Chen
Yen-Wen Chen
YHYi-Han Hsiao
Yi-Han Hsiao
HKHsin-Kuo Ko
Hsin-Kuo Ko
TJTien-Hsin Jeng
Tien-Hsin Jeng
KSKang-Cheng Su
Kang-Cheng Su
DPDiahn-Warng Perng
Diahn-Warng Perng
Patients with asthma are treated in primary healthcare facilities (PHCFs) in Taiwan, where the asthma control status associated with acute exacerbation (AE) and use of oral corticosteroids (OCS) and short-acting β2-agonist (SABA) inhalers remains unclear. A cross-sectional, close-ended, face-to-face questionnaire survey invited board-certified physicians who treat adult asthma patients in PHCFs. The contents of the questionnaire included three parts: rescue OCS to treat AE, regular OCS for asthma control, and AE-related adverse outcomes. There were 445 out of 500 physicians who completed the questionnaire, with 61% of them being non-pulmonologists. A substantial proportion of asthma patients needed rescue OCS or regular OCS each month, or ≥3 canisters of SABA inhalers per year. Approximately 86% of physicians reported their patients with ≥2 AE-related unscheduled visits to clinics or emergency departments in the past year. A total of 41% of physicians reported their patients receiving intubation or intensive care in the past year. A total of 92% of physicians prescribed rescue OCS ≤ 40 mg/day. A total of 92% of physicians prescribed rescue OCS for a duration of ≤7 days for AEs. A total of 85% of physicians prescribed regular OCS ≤ 10 mg/day for asthma control. This is the first study to present the perceptions of asthma-treating physicians on the use of OCS in PHCFs. In summary, 31% of physicians reported ≥ 6% of their patients needed OCS for asthma control and 41% of physicians reported their patients with adverse outcomes in the past year. Thus, the need to improve asthma control in Taiwan is suggested by our study results.